Anna Sergeevna Piatoikina (A S Pyatoykina, A S Pyatoikina, A S Piatoikina)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Smoking Cessation

Transcranial Direct Current Stimulation

Bipolar Disorder

Top Venues

Journal of molecular neuroscience : MN

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Schizophrenia research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Sergeevna Piatoikina, Tatiana Vladimirovna Zhilyaeva, Olga Vladimirovna Kostina, Evgeniya Sergeevna Zhukova, Tatiana Grigorievna Shcherbatyuk, Galina Elevna Mazo
Gender-related Characteristics of Oxidative Stress Severity and Cognitive Impairment in Patients With Schizophrenia. Journal of molecular neuroscience : MN (2023)
Tatiana Vladimirovna Zhilyaeva, Evgeny D Kasyanov, Anna Sergeevna Piatoikina, A S Blagonravova, Galina Elevna Mazo
[The association of serum folate levels with schizophrenia symptoms]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 122 (8) (2022)
Tatiana Vladimirovna Zhilyaeva, Anna Sergeevna Piatoikina, A P Bavrina, O V Kostina, E S Zhukova, Tatiana Grigorievna Shcherbatyuk, A S Blagonravova, E E Dubinina, Galina Elevna Mazo
Homocysteine in Schizophrenia: Independent Pathogenetic Factor with Prooxidant Activity or Integral Marker of Other Biochemical Disturbances? Schizophrenia research and treatment 2021 (2021)
Anna Sergeevna Piatoikina, Anastasia Alexandrovna Lyakhova, Ilya Vladimirovich Semennov, Tatyana Vladimirovna Zhilyaeva, Olga Vladimirovna Kostina, Ekaterina Sergeevna Zhukova, Tatyana Grigorievna Shcherbatyuk, Evgeny Dmitrievich Kasyanov, Anna Sergeevna Blagonravova, Galina Elevna Mazo
Association of antioxidant deficiency and the level of products of protein and lipid peroxidation in patients with the first episode of schizophrenia. Journal of molecular neuroscience : MN (2021)
Anna Sergeevna Piatoikina, Tatiana Vladimirovna Zhilyaeva, I V Semennov, G A Mishanov, A S Blagonravova, Galina Elevna Mazo
[The double-blind randomized placebo-controlled trial of N-acetylcysteine use in schizophrenia: preliminary results]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 120 (9) (2020)